RCM
SBC

Radcliffe Capital Management’s SBC Medical Group SBC Stock Holding History

Radcliffe Capital Management’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-299,896
Closed -$3.22M – 98
2023
Q4 		$3.22M Sell
299,896
-100
-0% -$1.07K 0.43% 62
2023
Q3 		$3.2M Sell
299,996
-4
-0% -$42 0.4% 93
2023
Q2 		$3.09M Hold
300,000
– – 0.26% 130
2023
Q1 		$3.13M Hold
300,000
– – 0.2% 165
2022
Q4 		$3.06M Buy
+300,000
New +$3.04M 0.1% 335

Other funds holding SBC

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Radcliffe Capital Management's SBC Position: Q1 2024 in Review

Radcliffe Capital Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 299,896 shares — an estimated $3.22M sold.

Radcliffe Capital Management first reported a position in SBC in Q4 2022 and held it in 5 quarters. The position peaked at $3.22M in Q4 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

  • Radcliffe Capital Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 299,896 SBC Medical Group shares in Q1 2024, an estimated $3.22M.
  • Radcliffe Capital Management first reported a position in SBC Medical Group in Q4 2022 and held it in 5 quarters.
  • Radcliffe Capital Management's SBC Medical Group position peaked at $3.22M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Radcliffe Capital Management's 13F filing for Q1 2024, filed 15 May 2024.